home : about us : ahead of print : current issue : archives search instructions : subscriptionLogin 
Users online: 6080      Small font sizeDefault font sizeIncrease font size Print this page Email this page
 CASE REPORT
Year : 2021  |  Volume : 16  |  Issue : 4  |  Page : 335-337

Carbamazepine-responsive chorea in a toddler with semilobar holoprosencephaly: Case report


1 Pediatrics Department, Universidade Positivo, Curitiba, Brazil
2 Department of Pediatric Neurology, Hospital Pequeno Príncipe, Curitiba, Brazil

Correspondence Address:
Dr. Daniel Almeida do Valle
Department of Pediatric Neurology, Hospital Pequeno Príncipe, Rua Desembargador Mota 1070, Curitiba
Brazil
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jpn.JPN_229_20

Rights and Permissions

Introduction: Holoprosencephaly (HPE) is a central nervous system malformation defined by incomplete separation of the prosencephalon in two hemispheres and determines a broad spectrum of clinical presentations based on extension of non-separation. Case Presentation: A 1 year and 8 months’ old girl with semilobar HPE and 18p deletion syndrome was admitted to our hospital due to viral bronchiolitis. During hospitalization, she started generalized choreic movements, with face dyskinesia and without any identified aggravating factors. Haloperidol, clonazepam, and valproic acid did not achieve an attenuation of the movement disorder. Significant symptom relief was obtained with the use of trihexyphenidyl, with reduced amplitude and frequency of movements, but hyperthermia compromised its use. Control of chorea with no important side effects was only achieved after the introduction of carbamazepine. Discussion: Despite significant morbidity, there are few cases described in the literature of chorea and movement disorders in HPE and no effective treatment strategies described. Carbamazepine is an antiepileptic drug that stabilizes voltage-gated sodium channels and is the most effective treatment for paroxysmal kinesigenic dyskinesia. Although it has been used successfully in the treatment of different movement disorders, few therapeutic trials have been reported. The mechanism by which carbamazepine alleviates chorea is still unknown but may be justified through the blocking of post-synaptic dopamine receptors and stimulation of cholinergic pathways.






[FULL TEXT] [PDF]*


        
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1047    
    Printed47    
    Emailed0    
    PDF Downloaded36    
    Comments [Add]    

Recommend this journal